Cargando…
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy
BACKGROUND: Leishmania infantum is an intracellular protozoan parasite which is endemic in countries of the Mediterranean Basin. Leishmaniosis is increasingly diagnosed in non-endemic areas due to the relocation of dogs from endemic areas and the travel of dogs to and from these areas. The prognosis...
Autores principales: | de Jong, Marja Klazina, Rappoldt, Aukje, Broere, Femke, Piek, Christine Jantine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184344/ https://www.ncbi.nlm.nih.gov/pubmed/37189181 http://dx.doi.org/10.1186/s13071-023-05777-2 |
Ejemplares similares
-
Retrospective Long-Term Evaluation of Miltefosine-Allopurinol Treatment in Canine Leishmaniosis
por: Gizzarelli, Manuela, et al.
Publicado: (2023) -
Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment
por: Santos, Marcos Ferreira, et al.
Publicado: (2019) -
Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol
por: Manna, Laura, et al.
Publicado: (2015) -
Canine leishmaniosis in South America
por: Dantas-Torres, Filipe
Publicado: (2009) -
Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey
por: Bourdeau, Patrick, et al.
Publicado: (2014)